or Try an Advanced Search...

    Technical Analysis for KNSA - Kiniksa Pharmaceuticals, Ltd.

    Grade Last Price % Change Price Change
    B 19.40 3.63% 0.68
    KNSA closed up 3.63 percent on Wednesday, May 1, 2024, on 1.42 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical KNSA trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.00%
    Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Earnings Movers Other 0.00%
    Above Upper BB Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Pocket Pivot Bullish Swing Setup 3.63%
    Older End-of-Day Signals for KNSA ...

       Recent Intraday Alerts

    Alert Time
    Up 5% about 11 hours ago
    Up 1 ATR about 12 hours ago
    Up 3% about 13 hours ago
    60 Minute Opening Range Breakout about 13 hours ago
    Rose Above 50 DMA about 13 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    KNSA Chart by TradingView
    Basic chart:

    Profile

    Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Disease Medication Pharmacology

    Is KNSA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 24 Kiniksa Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    Apr 24 Kiniksa Pharmaceuticals: Arcalyst Performs While Abiprubart Plans Take Shape
    Apr 24 Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript
    Apr 23 Kiniksa Pharmaceuticals, Ltd. (KNSA) Q1 2024 Earnings Call Transcript
    Apr 23 Kiniksa Pharmaceuticals, Ltd. 2024 Q1 - Results - Earnings Call Presentation
    Apr 23 Kiniksa Pharmaceuticals Ltd (KNSA) Q1 2024 Earnings Overview: Surpasses Revenue Forecasts
    Apr 23 Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates
    Apr 23 Kiniksa Pharmaceuticals reports mixed Q1 results; raises FY24 outlook
    Apr 23 Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
    Apr 22 Kiniksa Pharmaceuticals Q1 2024 Earnings Preview
    See more KNSA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.09
    52 Week Low 12.69
    Average Volume 406,896
    200-Day Moving Average 17.79
    50-Day Moving Average 19.17
    20-Day Moving Average 17.71
    10-Day Moving Average 17.86
    Average True Range 0.68
    RSI (14) 64.03
    ADX 23.56
    +DI 34.17
    -DI 17.19
    Chandelier Exit (Long, 3 ATRs) 17.87
    Chandelier Exit (Short, 3 ATRs) 18.61
    Upper Bollinger Bands 18.93
    Lower Bollinger Band 16.49
    Percent B (%b) 1.19
    BandWidth 13.80
    MACD Line -0.13
    MACD Signal Line -0.42
    MACD Histogram 0.2925
    Fundamentals Value
    Market Cap 686.95 Million
    Num Shares 35.4 Million
    EPS -0.11
    Price-to-Earnings (P/E) Ratio -176.36
    Price-to-Sales 5.38
    Price-to-Book 3.52
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 21.07
    Resistance 3 (R3) 21.05 20.49 20.79
    Resistance 2 (R2) 20.49 20.06 20.49 20.69
    Resistance 1 (R1) 19.94 19.80 20.22 19.96 20.60
    Pivot Point 19.38 19.38 19.51 19.38 19.38
    Support 1 (S1) 18.83 18.95 19.11 18.85 18.20
    Support 2 (S2) 18.27 18.69 18.27 18.11
    Support 3 (S3) 17.72 18.27 18.01
    Support 4 (S4) 17.74